Vagus Nerve
Conditions
Interventions
This is a randomized, double-blind, parallel-group clinical trial. The sample will consist of individuals diagnosed with CP, at levels I to V of the Gross Motor Function Classification System (GMFCS),
Sponsors
Faculdade de Filosofia e Ciências da Universidade Estadual Paulista - Campus de Marília
Faculdade de Filosofia e Ciências da Universidade Estadual Paulista - Campus de Marília
Eligibility
Age
5 Years to 18 Years
Inclusion criteria
Inclusion criteria: Individuals with cerebral palsy for the CP group and with typical development for the TD group; be between 5 and 18 years old; being able to remain at rest for the application of the assessment and intervention protocol
Exclusion criteria
Exclusion criteria: Have heart disease; have respiratory diseases; have metabolic diseases; who use medications that alter the autonomic control of heart rate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To investigate the effect of the dermoneuromodulation technique on the autonomic modulation of heart rate and its complexity, in children and adolescents with CP. | — |
Secondary
| Measure | Time frame |
|---|---|
| To characterize the behavior of cardiac autonomic function and investigate the effect of the dermoneuromodulation technique on resting heart rate, blood pressure and resting double product in children and adolescents with CP and typical development. | — |
Countries
Brazil
Contacts
Public ContactAna Marques
Faculdade de Filosofia e Ciências da Universidade Estadual Paulista - Campus de Marília
Outcome results
None listed